EUVIMED · CrossrefZeitschrift
Future Drug Discovery
ISSN 2631-3316 · Informa UK Limited
Neueste Artikel
Targeting Immune Checkpoint Pathways in Melanoma: Triumphs and Challenges
Overcoming the Shortcomings of Peptide-Based Therapeutics
Polyphenol and Self-Assembly: Metal Polyphenol Nanonetwork for Drug Delivery and Pharmaceutical Applications
Experimental Lipophilicity for Beyond Rule of 5 Compounds
An Open Science Rare Diseases Research Initiative: the University of North Carolina Catalyst
Application of biomimetic HPLC to estimate in vivo behavior of early drug discovery compounds
Perlecan-Targeted Nanoparticles for Drug Delivery to Triple-Negative Breast Cancer
Corrigendum
Forward-Looking Perspective On Publishing in Drug Discovery
Independent Consultancy in Drug Discovery and Development: a Personal Perspective
In silico and in vitro evaluation of brain penetration properties of selected nootropic agents
Benefits of Life in a Science Incubator
The Future of Antibiotics Lies in Combination Treatments
Pharma Expats: a Q&A With Two Who Made the Move to a Contract Research Organization
Prospects for Drug Discovery in Osteoarthritis
Compound optimization monitor (COMO) method for computational evaluation of progress in medicinal chemistry projects
Calcitonin Gene-Related Peptide: the New Era of Migraine Therapy
The Advent of Directed Protein Degraders in Drug Discovery
Welcome to the first issue of Future Drug Discovery
Practical Considerations for the Implementation of Adaptive Designs for Oncology Phase I Dose-Finding Trials
Targeting peripheral κ-opioid receptors for the non-addictive treatment of pain
Role of Neuraxial Drug Delivery in Cancer Pain Therapy
Artificial Intelligence in Drug Discovery: What is New, and What is Next?
Artificial Intelligence's Essential Role in the Process of Drug Discovery
Now the Future, We See Our Dreams: Artificial Intelligence in Drug Discovery
Influence of Placebo Analgesia in Pharmacological Treatment of Pain
A New Platform for Drug Discovery
Integrating Context of Tumor Biology and Vaccine Design to Shape Multidimensional Immunotherapies
How Polypharmacologic is Each Chemogenomics Library?
Peptide Drugs for Photopharmacology: How Much of a Safety Advantage Can Be Gained By Photocontrol?
EUVIMED